Putative biomarkers and therapeutic targets associated with radiation resistance

References

• Panis C, Pizzatti L, Abdelhay E. How can Proteomics Reach Cancer Biomarkers? Curr Proteomics 2013;10:136-49
   Google Scholar
• Hu R, Wang X, Zhan X. Multi-parameter systematic strategies for predictive, preventive and personalised medicine in cancer. EPMA J 2013;4:2
   Google Scholar
• Smith L, Qutob O, Watson MB, et al. Proteomic identification of putative biomarkers of radiotherapy resistance: a possible role for the 26S proteasome? Neoplasia 2009;11:1194-207
   PubMed Web of Science ®Google Scholar
• Skvortsova I, Skvortsov S, Stasyk T, et al. Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells. Proteomics 2008;8:4521-33
   Google Scholar
• Skvortsov S, Jimenez CR, Knol JC, et al. Radioresistant head and neck squamous cell carcinoma cells: intracellular signaling, putative biomarkers for tumor recurrences and possible therapeutic targets. Radiother Oncol 2011;101:177-82
   Google Scholar
• Kranenburg O, Emmink BL, Knol J, et al. Proteomics in studying cancer stem cell biology. Expert Rev Proteomics 2012;9:325-36
   Web of Science ®Google Scholar
• Clevers H. The cancer stem cell: premises, promises and challenges. Nat Med 2011;17:313-19
   PubMed Web of Science ®Google Scholar
• Zhang B, Qu JQ, Xiao L, et al. Identification of heat shock protein 27 as a radioresistance-related protein in nasopharyngeal carcinoma cells. J Cancer Res Clin Oncol 2012;138:2117-25
   PubMed Web of Science ®Google Scholar
• Lin TY, Chang JT, Wang HM, et al. Proteomics of the radioresistant phenotype in head-and-neck cancer: gp96 as a novel prediction marker and sensitizing target for radiotherapy. Int J Radiat Oncol Biol Phys 2010;78:246-56
   Google Scholar
• Skvortsova I, Skvortsov S, Popper BA, et al. Rituximab enhances radiation-triggered apoptosis in non-Hodgkin’s lymphoma cells via caspase-dependent and - independent mechanisms. J Radiat Res 2006;47:183-96
   PubMed Web of Science ®Google Scholar
• Feng XP, Yi H, Li MY, et al. Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics. Cancer Res 2010;70:3450-62
   PubMed Web of Science ®Google Scholar
• Svendsen A, Verhoeff JJ, Immervoll H, et al. Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma. Acta Neuropathol 2011;122:495-510
   PubMed Web of Science ®Google Scholar
• Chevalier F, Depagne J, Hem S, et al. Accumulation of cyclophilin A isoforms in conditioned medium of irradiated breast cancer cells. Proteomics 2012;12:1756-66
   Google Scholar
• Wu P, Zhang H, Qi L, et al. Identification of ERp29 as a biomarker for predicting nasopharyngeal carcinoma response to radiotherapy. Oncol Rep 2012;27:987-94
   PubMed Web of Science ®Google Scholar
• Ciocca DR, Arrigo AP, Calderwood SK. Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update. Arch Toxicol 2013;87:19-48
   PubMed Web of Science ®Google Scholar
• Nagaraja GM, Kaur P, Asea A. Role of human and mouse HspB1 in metastasis. Curr Mol Med 2012;12:1142-50
   Google Scholar
• Wei L, Liu TT, Wang HH, et al. Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-kappaB. Breast Cancer Res 2011;13:R101
   PubMed Web of Science ®Google Scholar
• Fu J, Koul D, Yao J, et al. Novel HSP90 inhibitor NVP-HSP990 targets cell-cycle regulators to ablate Olig2-positive glioma tumor-initiating cells. Cancer Res 2013;73:3062-74
   Google Scholar
• Gray PC, Vale W. Cripto/GRP78 modulation of the TGF-beta pathway in development and oncogenesis. FEBS Lett 2012;586:1836-45
   PubMed Web of Science ®Google Scholar
• Wu MJ, Jan CI, Tsay YG, et al. Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling. Mol Cancer 2010;9:283
   Google Scholar
• Hamelin C, Cornut E, Poirier F, et al. Identification and verification of heat shock protein 60 as a potential serum marker for colorectal cancer. FEBS J 2011;278:4845-59
   PubMed Web of Science ®Google Scholar
• Sato Y, Harada K, Sasaki M, et al. Heat shock proteins 27 and 70 are potential biliary markers for the detection of cholangiocarcinoma. Am J Pathol 2012;180:123-30
   Google Scholar
• Lee E, Nichols P, Groshen S, et al. GRP78 as potential predictor for breast cancer response to adjuvant taxane therapy. Int J Cancer 2011;128:726-31
   PubMed Web of Science ®Google Scholar
• Wang K, Zhang T, Dong Q, et al. Redox homeostasis: the linchpin in stem cell self-renewal and differentiation. Cell Death Dis 2013;4:e537
   PubMed Web of Science ®Google Scholar
• Kim MH, Kim HB, Yoon SP, et al. Colon cancer progression is driven by APEX1-mediated upregulation of Jagged. J Clin Invest 2013;123(8):3211-30
   Web of Science ®Google Scholar
• Minisini AM, Di LC, Mansutti M, et al. Topoisomerase IIalpha and APE/ref-1 are associated with pathologic response to primary anthracycline-based chemotherapy for breast cancer. Cancer Lett 2005;224:133-9
   Google Scholar
• Prabhu VV, Siddikuzzaman Grace VM, Guruvayoorappan C. Targeting tumor metastasis by regulating Nm23 gene expression. Asian Pac J Cancer Prev 2012;13:3539-48
   Google Scholar
• Almgren MA, Henriksson KC, Fujimoto J, Chang CL. Nucleoside diphosphate kinase A/nm23-H1 promotes metastasis of NB69-derived human neuroblastoma. Mol Cancer Res 2004;2:387-94
   PubMedGoogle Scholar
• Kim SH, Lee SY, Park HR, et al. Nuclear localization of Nm23-H1 in head and neck squamous cell carcinoma is associated with radiation resistance. Cancer 2011;117:1864-73
   PubMed Web of Science ®Google Scholar
• Yoon CH, Hyun KH, Kim RK, et al. The small GTPase Rac1 is involved in the maintenance of stemness and malignancies in glioma stem-like cells. FEBS Lett 2011;585:2331-8
   PubMed Web of Science ®Google Scholar
• Koh MS, Moon A. Activation of H-Ras and Rac1 correlates with epidermal growth factor-induced invasion in Hs578T and MDA-MB-231 breast carcinoma cells. Biochem Biophys Res Commun 2011;406:25-9
   Google Scholar
• Ma Q, Cavallin LE, Yan B, et al. Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi’s sarcoma. Proc Natl Acad Sci USA 2009;106:8683-8
   PubMedGoogle Scholar
• Iwashima F, Yoshimoto T, Minami I, et al. Aldosterone induces superoxide generation via Rac1 activation in endothelial cells. Endocrinology 2008;149:1009-14
   PubMed Web of Science ®Google Scholar
• Gastonguay A, Berg T, Hauser AD, et al. The role of Rac1 in the regulation of NF-kappaB activity, cell proliferation, and cell migration in non-small cell lung carcinoma. Cancer Biol Ther 2012;13:647-56
   PubMed Web of Science ®Google Scholar
• Akunuru S, Palumbo J, Zhai QJ, Zheng Y. Rac1 targeting suppresses human non-small cell lung adenocarcinoma cancer stem cell activity. PLoS One 2011;6:e16951
   Google Scholar
• Li XR, Ji F, Ouyang J, et al. Overexpression of RhoA is associated with poor prognosis in hepatocellular carcinoma. Eur J Surg Oncol 2006;32:1130-4
   PubMed Web of Science ®Google Scholar
• Benitah SA, Valeron PF, van Aelst L, et al. Rho GTPases in human cancer: an unresolved link to upstream and downstream transcriptional regulation. Biochim Biophys Acta 2004;1705:121-32
   PubMed Web of Science ®Google Scholar
• Mendoza-Catalan MA, Cristobal-Mondragon GR, me-Gomez J, et al. Nuclear expression of Rac1 in cervical premalignant lesions and cervical cancer cells. BMC Cancer 2012;12:116
   PubMed Web of Science ®Google Scholar
• Dokmanovic M, Hirsch DS, Shen Y, Wu WJ. Rac1 contributes to trastuzumab resistance of breast cancer cells: rac1 as a potential therapeutic target for the treatment of trastuzumab-resistant breast cancer. Mol Cancer Ther 2009;8:1557-69
   PubMedGoogle Scholar
• Tilghman SL, Townley I, Zhong Q, et al. Proteomic signatures of acquired letrozole resistance in breast cancer: suppressed estrogen signaling and increased cell motility and invasiveness. Mol Cell Proteomics 2013;12(9):2440-55
   Google Scholar
• Jeong HG, Cho HJ, Chang IY, et al. Rac1 prevents cisplatin-induced apoptosis through down-regulation of p38 activation in NIH3T3 cells. FEBS Lett 2002;518:129-34
   PubMedGoogle Scholar
• Kato T, Fujita Y, Nakane K, et al. CCR1/CCL5 interaction promotes invasion of taxane-resistant PC3 prostate cancer cells by increasing secretion of MMPs 2/9 and by activating ERK and Rac signaling. Cytokine 2013;64(1):251-7
   PubMed Web of Science ®Google Scholar
• Chen SF, Nieh S, Jao SW, et al. Quercetin suppresses drug-resistant spheres via the p38 MAPK-Hsp27 apoptotic pathway in oral cancer cells. PLoS One 2012;7:e49275
   PubMed Web of Science ®Google Scholar
• McConnell JR, McAlpine SR. Heat shock proteins 27, 40, and 70 as combinational and dual therapeutic cancer targets. Bioorg Med Chem Lett 2013;23:1923-8
   PubMed Web of Science ®Google Scholar
• Ischia J, Saad F, Gleave M. The promise of heat shock protein inhibitors in the treatment of castration resistant prostate cancer. Curr Opin Urol 2013;23:194-200
   PubMed Web of Science ®Google Scholar
• Schilling D, Bayer C, Li W, et al. Radiosensitization of normoxic and hypoxic h1339 lung tumor cells by heat shock protein 90 inhibition is independent of hypoxia inducible factor-1alpha. PLoS One 2012;7:e31110
   PubMed Web of Science ®Google Scholar
• Musha A, Yoshida Y, Takahashi T, et al. Synergistic effect of heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin and X-rays, but not carbon-ion beams, on lethality in human oral squamous cell carcinoma cells. J Radiat Res 2012;53:545-50
   Google Scholar
• Djuzenova CS, Blassl C, Roloff K, et al. Hsp90 inhibitor NVP-AUY922 enhances radiation sensitivity of tumor cell lines under hypoxia. Cancer Biol Ther 2012;13:425-34
   PubMed Web of Science ®Google Scholar
• Neckers L, Workman P. Hsp90 molecular chaperone inhibitors: are we there yet? Clin Cancer Res 2012;18:64-76
   PubMed Web of Science ®Google Scholar
• Kelley MR, Luo M, Reed A, et al. Functional analysis of novel analogues of E3330 that block the redox signaling activity of the multifunctional AP endonuclease/redox signaling enzyme APE1/Ref-1. Antioxid Redox Signal 2011;14:1387-401
   Google Scholar
• Fishel ML, Jiang Y, Rajeshkumar NV, et al. Impact of APE1/Ref-1 redox inhibition on pancreatic tumor growth. Mol Cancer Ther 2011;10:1698-708
   PubMed Web of Science ®Google Scholar
• Kelley M. DNA repair in cancer therapy: molecular targets and clinical applications. Elsevier, Inc; San Diego, CA, USA: 2012
   Google Scholar
• Katz E, Sims AH, Sproul D, et al. Targeting of Rac GTPases blocks the spread of intact human breast cancer. Oncotarget 2012;3:608-19
   PubMedGoogle Scholar
• Nagase M, Fujita T. Role of Rac1-mineralocorticoid-receptor signalling in renal and cardiac disease. Nat Rev Nephrol 2013;9:86-98
   PubMed Web of Science ®Google Scholar